Page last updated: 2024-08-23

staurosporine and Autoimmune Diabetes

staurosporine has been researched along with Autoimmune Diabetes in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (33.33)	18.2507
2000's	2 (66.67)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Schran, H; Wang, Y; Yin, OQ	1
Allison, J; Beck, D; Brady, JL; Elefanty, A; Huang, DC; Kay, TW; Kosaka, H; Lew, AM; Strasser, A; Thomas, H	1
Bomford, J; Frighi, V; Garrido, MC; Ng, LL; Simmons, D	1

Trials

1 trial(s) available for staurosporine and Autoimmune Diabetes

Article	Year
A mechanism-based population pharmacokinetic model for characterizing time-dependent pharmacokinetics of midostaurin and its metabolites in human subjects. Clinical pharmacokinetics, 2008, Volume: 47, Issue:12 Topics: Administration, Oral; Aged; Algorithms; Chromatography, High Pressure Liquid; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Administration Schedule; Enzyme Inhibitors; Female; Humans; Male; Middle Aged; Models, Biological; Protein Kinase C; Staurosporine; Time Factors	2008

Article

Year

A mechanism-based population pharmacokinetic model for characterizing time-dependent pharmacokinetics of midostaurin and its metabolites in human subjects.

Clinical pharmacokinetics, 2008, Volume: 47, Issue:12

Topics: Administration, Oral; Aged; Algorithms; Chromatography, High Pressure Liquid; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Administration Schedule; Enzyme Inhibitors; Female; Humans; Male; Middle Aged; Models, Biological; Protein Kinase C; Staurosporine; Time Factors

2008

Other Studies

2 other study(ies) available for staurosporine and Autoimmune Diabetes

Article	Year
Transgenic overexpression of human Bcl-2 in islet beta cells inhibits apoptosis but does not prevent autoimmune destruction. International immunology, 2000, Volume: 12, Issue:1 Topics: Age of Onset; Animals; Apoptosis; B7-1 Antigen; CD8-Positive T-Lymphocytes; Diabetes Mellitus, Type 1; Disease Models, Animal; Drug Resistance; Humans; Interleukin-2; Islets of Langerhans; Mice; Mice, Transgenic; Proto-Oncogene Proteins c-bcl-2; Staurosporine; Streptozocin	2000
Effect of protein kinase C modulators on the leucocyte Na+/H+ antiport in type 1 (insulin-dependent) diabetic subjects with albuminuria. Diabetologia, 1990, Volume: 33, Issue:5 Topics: Albuminuria; Alkaloids; Amiloride; Blood Glucose; Carrier Proteins; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Glycated Hemoglobin; Humans; Hydrogen-Ion Concentration; In Vitro Techniques; Insulin; Kinetics; Leukocytes; Protein Kinase C; Sodium-Hydrogen Exchangers; Staurosporine	1990

Article

Year

Transgenic overexpression of human Bcl-2 in islet beta cells inhibits apoptosis but does not prevent autoimmune destruction.

International immunology, 2000, Volume: 12, Issue:1

Topics: Age of Onset; Animals; Apoptosis; B7-1 Antigen; CD8-Positive T-Lymphocytes; Diabetes Mellitus, Type 1; Disease Models, Animal; Drug Resistance; Humans; Interleukin-2; Islets of Langerhans; Mice; Mice, Transgenic; Proto-Oncogene Proteins c-bcl-2; Staurosporine; Streptozocin

2000

Effect of protein kinase C modulators on the leucocyte Na+/H+ antiport in type 1 (insulin-dependent) diabetic subjects with albuminuria.

Diabetologia, 1990, Volume: 33, Issue:5

Topics: Albuminuria; Alkaloids; Amiloride; Blood Glucose; Carrier Proteins; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Glycated Hemoglobin; Humans; Hydrogen-Ion Concentration; In Vitro Techniques; Insulin; Kinetics; Leukocytes; Protein Kinase C; Sodium-Hydrogen Exchangers; Staurosporine

1990